Christopher P. Boone, PhD, FACHE, FHIMSS

Adjunct Assistant Professor of Health Administration

Christopher P Boone

Christopher P. Boone, PhD, FACHE, FHIMSS teaches Healthcare Information Technology: Public Policy and Management (MHA-GP 4842) at NYU Wagner. The course asks how health leaders should govern data sharing, protect patient privacy, and invest in technologies like artificial intelligence when the return is uncertain and the tools change quickly. He has worked on these questions for two decades from inside industry, government, and the community.

Dr. Boone is Group Vice President of Research Services at Oracle Health & Life Sciences, where he leads an extensive global organization that uses real-world data and AI to help life sciences companies, health systems, and researchers understand how treatments perform in everyday care. Across three Fortune 100 companies, his work has centered on building and transforming the organizations that turn health data into evidence. At Pfizer, he founded the Global Medical Epidemiology group in research and development and later led real-world data and analytics, establishing data partnerships with Flatiron Health and Tempus. At AbbVie, as Vice President and Global Head of Health Economics & Outcomes Research, he turned a traditional research function into a global evidence organization serving every therapeutic area. Earlier, he held leadership roles at the American Heart Association.

His policy work connects directly to the federal programs students study in this course. In 2012 the U.S. Comptroller General appointed him to the federal Health Information Technology Policy Committee, where he held the seat representing patients and consumers as the committee advised national strategy for electronic health record adoption and data exchange. He is now a member of the Board of Governors of the Patient-Centered Outcomes Research Institute (PCORI), appointed in 2022 and reappointed in 2026 to a second term through 2032. He previously served on the boards of Global Medical Response, a national emergency medical services company, and the American Society of Hematology Research Collaborative.

In 2026 he founded Twelve-Mile, a Dallas compact that brings major employers together to close a 17-year gap in life expectancy between neighborhoods just twelve miles apart, with progress reported publicly each year. He is completing a book, Real-World Intelligence: A Leader’s Guide to Evidence, Practice, and Governance in the Age of Medical AI.

A DataIQ 100 honoree and member of the Executive Leadership Council, Dr. Boone holds a Ph.D. in Public Affairs from the University of Texas at Dallas, an M.S. in Healthcare Administration from the University of Texas at Arlington, and a B.S. in Management Information Systems from the University of Tulsa. His executive education includes programs at the Harvard Kennedy School and at Dartmouth’s Tuck School of Business, where he completed executive programs in AI and Data for Strategic Advantage and Leading Organizational Change. He also holds the Effective AI Oversight for Directors Certificate from Carnegie Mellon’s Heinz College.

In the classroom, he focuses on the decisions health leaders actually face: how to build a business case, choose among vendors, weigh cost against benefit, and make sure new technology widens access to care instead of narrowing it.